Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.
about
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysisObesity in cancer survivalWeight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer.The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancerRacial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States.The Impact of Obesity on Patient Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer.Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.Predictors in the outcome of 125I brachytherapy as monotherapy for prostate cancer.Clinical management of obese patients with cancer.Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients.Body mass index and mortality in prostate cancer patients: a dose-response meta-analysis.Predicting prostate cancer progression: protocol for a retrospective cohort study to identify prognostic factors for prostate cancer outcomes using routine primary care data.Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients
P2860
Q24625223-2AE43C84-F0B1-49B3-92D5-81D2047C69ACQ26863606-9A1C3CB1-1584-42D4-80A7-D2AFF4573BD7Q34768848-7C9C27D7-33F1-40F3-9B74-6E5CB3228091Q35292828-269D0BC9-F07D-4B55-A572-A69888F1A548Q36090379-0583A658-A552-4955-994B-9D48B8DE6309Q37115967-222D05A3-C8F1-4354-8A9B-D2649302A7AEQ37159100-DEB994B0-8077-45C9-8BFD-DBE2534AD813Q37636973-17BE707A-1DBE-4488-A862-1BB3A7290D2DQ37821905-33DDCDB6-1FA0-4632-928E-FF69E41ABABBQ38121736-819D8789-0BF9-4580-975E-0BC64BC881D3Q38175843-DEE76118-4096-48A3-9F6A-AB95A19D629CQ38692737-8C0C22C4-324B-49A1-B384-79DDACFEF8B6Q48121156-6E89A3AE-67E7-4145-B30C-A91317C1B68CQ57307192-8C8825FB-F209-466F-BF6C-A92958A1645B
P2860
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Body mass index is not a progn ...... en treated with brachytherapy.
@en
Body mass index is not a progn ...... en treated with brachytherapy.
@nl
type
label
Body mass index is not a progn ...... en treated with brachytherapy.
@en
Body mass index is not a progn ...... en treated with brachytherapy.
@nl
prefLabel
Body mass index is not a progn ...... en treated with brachytherapy.
@en
Body mass index is not a progn ...... en treated with brachytherapy.
@nl
P2093
P1433
P1476
Body mass index is not a progn ...... men treated with brachytherapy
@en
P2093
J Alfred Witjes
J L H Ruud Bosch
Jan J Battermann
Karel A Hinnen
Marco van Vulpen
P356
10.1111/J.1464-410X.2009.08687.X
P407
P577
2009-06-10T00:00:00Z